Meningococcal Vaccine Suppliers & Bulk Manufacturers
Available Forms: Vial or pre-filled syringe (injectable), Conjugate vaccines
Available Strengths: 0.5 mL
Reference Brands: Menactra, Menveo(US)
Category:
Vaccines
Meningococcal vaccines stimulate immunity by introducing purified polysaccharide or protein antigens from Neisseria meningitidis bacteria. They produce protective antibodies, preventing meningococcal meningitis and septicemia. Benefits include long-lasting immunity, outbreak control, and protection for high-risk populations, supporting global efforts to reduce meningococcal disease morbidity and mortality.
Meningococcal Vaccine is available in Vial or pre-filled syringe (injectable), Conjugate vaccines
and strengths such as 0.5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Meningococcal Vaccine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Meningococcal Vaccine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Meningococcal vaccines are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and manufacturing quality in compliance with GMP and IVDR standards. In the US, FDA approval involves extensive clinical data, while in the EU, CE marking certifies conformity with in vitro diagnostic regulations. These vaccines undergo validation, stability testing, and quality audits, with comprehensive documentation including safety profiles, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe, effective meningococcal vaccines vital for disease prevention, outbreak control, and protection of high-risk populations globally.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing